RecruitingNot ApplicableNCT04795843

Exercise and Patient Education Compared With Usual Care in Patients With Hip Dysplasia

MovetheHip-trial: The Effectiveness of Exercise and Patient Education Compared With Usual Care on Self-reported Pain in Patients With Hip Dysplasia


Sponsor

University of Aarhus

Enrollment

200 participants

Start Date

Apr 16, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This effectiveness trial will investigate if patients with hip dysplasia randomised to exercise and patient education have a different mean change in self-reported pain measured by the Copenhagen Hip and Groin Outcome Score (HAGOS) compared with those randomised to usual care over a six-month follow-up period. Participating patients will be allocated to either exercise and patient education or usual care. Alongside this, a health-economic study and a process-evaluation study will be conducted.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This Scandinavian study is comparing a structured exercise and patient education program against usual care for adults with hip dysplasia — a condition where the hip socket is too shallow to fully cover the femoral head (ball of the hip joint), causing pain and instability. Hip dysplasia typically requires surgery (periacetabular osteotomy, or PAO), but not everyone is a surgical candidate, and some patients wait a year or more for surgery. This study tests whether conservative treatment (exercise + education) can meaningfully reduce pain and improve function in the meantime. Participants are adults aged 18–50 with radiographically confirmed hip dysplasia and hip/groin pain for at least 3 months who are on the PAO waiting list, unwilling to have PAO, or not surgical candidates. You may be eligible if... - You are between 18 and 50 years old - You have confirmed hip dysplasia (CE angle 10–25°, AI angle >10°) on X-ray - You have had hip or groin pain as your primary complaint for at least 3 months - You are waiting for PAO surgery, unwilling to have PAO, or not a surgical candidate You may NOT be eligible if... - Your hip pain score is already above 80 on the HAGOS questionnaire (very severe) - Your BMI is above 35 - You have had previous hip or pelvic surgery on the affected side - You have hip arthritis, Calve Legg Perthes disease, or epiphysiolysis - You have a physical, neurological, or rheumatic condition severely affecting hip function - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExercise and patient education

Over a period of 6-months, patients will be offered eight one-to-one supervised training sessions. In these sessions, patients will be instructed in a home-based exercise programme and given patient education. The programme includes four exercises covering strength and stability training. The exercises will be performed in sets of three with a minimum of 5 repetitions, and patients will be instructed to perform a minimum of three training sessions each week. Each of the exercises can be progressed through three levels of difficulty, allowing for individualised treatment with regard to exercise quality and perceived exertion according to the Borg CR10 scale. Exercises will be performed on a perceived exertion level from somewhat hard (level 5) to very hard (level 7). Patient education includes pain management, a focus on exercise adherence and progression, and advice on physical activity.

OTHERUsual Care

Patients will follow usual care, including an individual consultation on self-management of hip symptoms and general advice on exercise and physical activity.


Locations(2)

Aarhus University Hospital

Aarhus N, Denmark

Silkeborg Regional Hospital.

Silkeborg, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04795843


Related Trials